Isolation and characterization of head and neck cancer-derived peritumoral and cancer-associated fibroblasts

被引:16
|
作者
Zhou, Jiefu [1 ]
Schwenk-Zieger, Sabina [1 ]
Kranz, Gisela [1 ]
Walz, Christoph [2 ]
Klauschen, Frederik [2 ]
Dhawan, Sharduli [1 ]
Canis, Martin [1 ,3 ]
Gires, Olivier [1 ,3 ]
Haubner, Frank [1 ]
Baumeister, Philipp [1 ,3 ]
Kohlbauer, Vera [1 ]
机构
[1] Ludwig Maximilians Univ LMU, Grosshadern Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Munich, Germany
[2] Ludwig Maximilians Univ LMU Munich, Inst Pathol, Fac Med, Munich, Germany
[3] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Clin Cooperat Grp Personalized Radiotherapy Head, Neuherberg, Germany
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
head and neck squamous cell carcinoma; cancer-associated fibroblasts; peritumoral fibroblasts; tumor microenvironment; angiogenesis; ANGIOGENESIS; SUBPOPULATIONS; BIOLOGY;
D O I
10.3389/fonc.2022.984138
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IntroductionHead and neck squamous cell carcinomas (HNSCC) are characterized by strong cellular and molecular heterogeneity and treatment resistance entailing poor survival. Besides cell-intrinsic properties, carcinoma cells receive important cues from non-malignant cells within the tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs) are a major component of the TME that impact on the molecular make-up of malignant cells and have a decisive function in tumor progression. However, the potential functionality of fibroblasts within tumor-adjacent, macroscopically normal tissue remains poorly explored. MethodsHere, we isolated primary peritumoral fibroblasts (PtFs) from macroscopically normal tissue in vicinity of primary human papillomavirus-negative and -positive oropharyngeal HNSCC and compared their phenotype and functionality with matched CAFs (n = 5 pairs) and with human oral fibroblasts (hOFs). ResultsExpression patterns of CD90, CD73, CD105, smooth muscle actin, Vimentin, and S100A4 were comparable in PtFs, CAFs, and hOFs. Cell proliferation and doubling times of CAFs and PtFs were heterogeneous across patients (n =2 PtF>CAF; n = 1 CAF>PtF; n = 2 CAF=PtF) and reflected inferior growth than hOFs. Furthermore, PtFs displayed an reduced heterogeneity in cell size compared to matched CAFs, which were characterized by the presence of single large cells. Overall, conditioned supernatants from CAFs had more frequently growth-promoting effects on a panel of carcinoma cell lines of the upper aerodigestive tract carcinoma cell lines (Cal27, Cal33, FaDu, and Kyse30), whereas significant differences in migration-inducing effects demonstrated a higher potential of PtFs. Except for Kyse30, CAFs were significantly superior to hOFs in promoting proliferation, while PtFs induced stronger migration than hOFs in all carcinoma lines tested. Analysis of soluble factors demonstrated significantly increased VEGF-A production in CAFs (except in pat.8), and significantly increased PDGF-BB production in PtFs of two patients. Tube formation assays confirmed a significantly enhanced angiogenic potential of conditioned supernatants from CAFs compared to hOFs on human umbilical vascular endothelial cells (HUVECs) in vitro. DiscussionHence, matched CAFs and PtFs present in HNSCC patients are heterogeneous in their proliferation-, migration-, and angiogenesis-promoting capacity. Despite this heterogeneity, CAFs induced stronger carcinoma cell proliferation and HUVEC tube formation overall, whereas PtFs promoted migration of tumor cells more strongly.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] The Role of Cancer-Associated Fibroblasts in Prostate Cancer Tumorigenesis
    Bonollo, Francesco
    Thalmann, George N.
    Kruithof-de Julio, Marianna
    Karkampouna, Sofia
    CANCERS, 2020, 12 (07) : 1 - 28
  • [42] Cancer-associated fibroblasts in pancreatic adenocarcinoma
    Pan, Boju
    Liao, Quan
    Niu, Zheyu
    Zhou, Li
    Zhao, Yupei
    FUTURE ONCOLOGY, 2015, 11 (18) : 2603 - 2610
  • [43] Novel signatures of cancer-associated fibroblasts
    Bozoky, Benedek
    Savchenko, Andrii
    Csermely, Peter
    Korcsmaros, Tamas
    Dul, Zoltan
    Ponten, Fredrik
    Szekely, Laszlo
    Klein, George
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (02) : 286 - 293
  • [44] Cancer-associated fibroblasts as targets for immunotherapy
    Kakarla, Sunitha
    Song, Xiao-Tong
    Gottschalk, Stephen
    IMMUNOTHERAPY, 2012, 4 (11) : 1129 - 1138
  • [45] Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
    Zhang, Zhongsong
    Chen, Long
    CANCER NANOTECHNOLOGY, 2025, 16 (01)
  • [46] Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy
    Raskov, Hans
    Orhan, Adile
    Gaggar, Shruti
    Gogenur, Ismail
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [47] Rethinking the Roles of Cancer-Associated Fibroblasts in Pancreatic Cancer
    Francescone, Ralph
    Crawford, Howard C.
    Vendramini-Costa, Debora Barbosa
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2024, 17 (05): : 737 - 743
  • [48] Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy
    Glabman, Raisa A.
    Choyke, Peter L.
    Sato, Noriko
    CANCERS, 2022, 14 (16)
  • [49] TGF-Beta-Activated Cancer-Associated Fibroblasts Limit Cetuximab Efficacy in Preclinical Models of Head and Neck Cancer
    Yegodayev, Ksenia M.
    Novoplansky, Ofra
    Golden, Artemiy
    Prasad, Manu
    Levin, Liron
    Jagadeeshan, Sankar
    Zorea, Jonathan
    Dimitstein, Orr
    Joshua, Ben-Zion
    Cohen, Limor
    Khrameeva, Ekaterina
    Elkabets, Moshe
    CANCERS, 2020, 12 (02)
  • [50] Cancer-Derived Extracellular Vesicle ITGB2 Promotes the Progression of Triple-Negative Breast Cancer via the Activation of Cancer-Associated Fibroblasts
    Fan, Jingjing
    Sha, Tong
    Ma, Binlin
    GLOBAL CHALLENGES, 2025, 9 (03)